Table 1

Characteristics of study infants by treatment group

Variable rhG-CSF (n=13) Placebo (n=15)
Gestation (weeks)28 (25–33)28 (25–32)
Birth weight (g)1030 (679–1380)980 (650–1350)
Sex Males34
Females1011
Age at recruitment (hours)86 (39–670)124 (29–652)
Confirmed infection68
Culture negative infection56
Doubtful infection21
  • Where applicable, results are presented as median (range).

  • rhG-CSF, recombinant human granulocyte colony stimulating factor.